Regulation of ABC transporter function via phosphorylation by protein kinases

Current Pharmaceutical Biotechnology

Volumn 12, Issue 4, 2011, Pages 621-635

  Stolarczyk, Elzbieta I ^a   Reiling, Cassandra J ^a   Paumi, Christian M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

ABC transporter; CK2; Kinase; LC MS; Phosphorylation; PKA; PKC; Regulation

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER G1; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; PROTEIN ABCC; PROTEIN ABCC2; PROTEIN ABCC8; PROTEIN ABCC9; PROTEIN ABCD; PROTEIN KINASE; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BINDING SITES; DRUG RESISTANCE, MULTIPLE; HUMANS; PHOSPHORYLATION; PROTEIN KINASES;

EID: 79953794574     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920111795164075     Document Type: Review

References (170)

1. Gottesman, M. M.; Ambudkar, S. V. Overview: ABC transporters and human disease. J. Bioenerg. Biomembr., 2001, 33, 453-458.
2. Dean, M.; Allikmets, R. Evolution of ATP-binding cassette transporter genes. Curr. Opin. Genet. Dev., 1995, 5, 779-785.
3. Dean, M. ABC transporters, drug resistance, and cancer stem cells. J. Mammary Gland Biol. Neoplasia, 2009, 14, 3-9.
4. Paumi, C. M.; Chuk, M.; Snider, J.; Stagljar, I.; Michaelis, S. ABC transporters in Saccharomyces cerevisiae and their interactors: new technology advances the biology of the ABCC (MRP) subfamily. Microbiol. Mol. Biol. Rev., 2009, 73, 577-593.
5. Haimeur, A.; Conseil, G.; Deeley, R. G.; Cole, S. P. The MRPrelated and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Curr. Drug Metab., 2004, 5, 21-53.
6. Taglicht, D.; Michaelis, S. Saccharomyces cerevisiae ABC proteins and their relevance to human health and disease. Methods Enzymol., 1998, 292, 130-162.
7. Cordwell, S. J.; Thingholm, T. E. Technologies for plasma membrane proteomics. Proteomics, 2009, 10(4), 611-627.
8. Cohen, P. The role of protein phosphorylation in human health and disease. The Sir Hans Krebs Medal Lecture. Eur. J. Biochem., 2001, 268, 5001-5010.
9. Johnson, L. N. The regulation of protein phosphorylation. Biochem. Soc. Trans., 2009, 37, 627-641.
10. Salazar, C.; Hofer, T. Multisite protein phosphorylation--from molecular mechanisms to kinetic models FEBS J., 2009, 276, 3177-3198.
11. Ame, M. V.; Baroni, M. V.; Galanti, L. N.; Bocco, J. L.; Wunderlin, D. A. Effects of microcystin-LR on the expression of P-glycoprotein in Jenynsia multidentata. Chemosphere, 2009, 74, 1179-1186.
12. Contardo-Jara, V.; Pflugmacher, S.; Wiegand, C. Multi-xenobioticresistance a possible explanation for the insensitivity of bivalves towards cyanobacterial toxins. Toxicon, 2008, 52, 936-943.
13. Pearson, L. A.; Hisbergues, M.; Borner, T.; Dittmann, E.; Neilan, B. A. Inactivation of an ABC transporter gene, mcyH, results in loss of microcystin production in the cyanobacterium Microcystis aeruginosa PCC 7806. Appl. Environ. Microbiol., 2004, 70, 6370-6378.
14. See, R. H.; Caday-Malcolm, R. A.; Singaraja, R. R.; Zhou, S.; Silverston, A.; Huber, M. T.; Moran, J.; James, E. R.; Janoo, R.; Savill, J. M.; Rigot, V.; Zhang, L. H.; Wang, M.; Chimini, G.; Wellington, C. L.; Tafuri, S. R.; Hayden, M. R. Protein kinase A site-specific phosphorylation regulates ATP-binding cassette A1 (ABCA1)-mediated phospholipid efflux. J. Biol. Chem., 2002, 277, 41835-41842.
15. Roosbeek, S.; Peelman, F.; Verhee, A.; Labeur, C.; Caster, H.; Lensink, M. F.; Cirulli, C.; Grooten, J.; Cochet, C.; Vandekerckhove, J.; Amoresano, A.; Chimini, G.; Tavernier, J.; Rosseneu, M. Phosphorylation by protein kinase CK2 modulates the activity of the ATP binding cassette A1 transporter J. Biol. Chem., 2004, 279, 37779-37788.
16. Martinez, L. O.; Agerholm-Larsen, B.; Wang, N.; Chen, W.; Tall, A. R. Phosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-I. J. Biol. Chem., 2003, 278, 37368-37374.
17. Yamauchi, Y.; Hayashi, M.; Abe-Dohmae, S.; Yokoyama, S. Apolipoprotein A-I activates protein kinase C alpha signaling to phosphorylate and stabilize ATP binding cassette transporter A1 for the high density lipoprotein assembly. J. Biol. Chem., 2003, 278, 47890-47897.
18. Dean, M.; Annilo, T. Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates. Annu. Rev. Genomics Hum. Genet, 2005, 6, 123-142.
19. Dean, M. The genetics of ATP-binding cassette transporters. Methods Enzymol., 2005, 400, 409-429.
20. Ueda, K.; Cornwell, M. M.; Gottesman, M. M.; Pastan, I.; Roninson, I. B.; Ling, V.; Riordan, J. R. The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem. Biophys. Res. Commun., 1986, 141, 956-962.
21. Chambers, T. C. Identification of phosphorylation sites in human MDR1 P-glycoprotein. Methods Enzymol., 1998, 292, 328-342.
22. Chambers, T. C.; McAvoy, E. M.; Jacobs, J. W.; Eilon, G. Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells. J. Biol. Chem., 1990, 265, 7679-7686.
23. Chambers, T. C.; Pohl, J.; Glass, D. B.; Kuo, J. F. Phosphorylation by protein kinase C and cyclic AMP-dependent protein kinase of synthetic peptides derived from the linker region of human Pglycoprotein. Biochem. J., 1994, 299(Pt 1), 309-315.
24. Chambers, T. C.; Pohl, J.; Raynor, R. L.; Kuo, J. F. Identification of specific sites in human P-glycoprotein phosphorylated by protein kinase C. J. Biol. Chem., 1993, 268, 4592-4595.
25. Chambers, T. C.; Zheng, B.; Kuo, J. F. Regulation by phorbol ester and protein kinase C inhibitors, and by a protein phosphatase inhibitor (okadaic acid), of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cells. Mol. Pharmacol., 1992, 41, 1008-1015.
26. Cohen, P. The regulation of protein function by multisite phosphorylation--a 25 year update. Trends Biochem. Sci., 2000, 25, 596-601.
27. Glavy, J. S.; Horwitz, S. B.; Orr, G. A. Identification of the in vivo phosphorylation sites for acidic-directed kinases in murine mdr1b P-glycoprotein. J. Biol. Chem., 1997, 272, 5909-5914.
28. Glavy, J. S.; Wolfson, M.; Nieves, E.; Han, E. K.; Yang, C. P.; Horwitz, S. B.; Orr, G. A. Identification of in vivo phosphorylation sites for basic-directed kinases in murine mdr1b P-glycoprotein by combination of mass spectrometry and site-directed mutagenesis. Methods Enzymol., 1998, 292, 342-358.
29. Goodfellow, H. R.; Sardini, A.; Ruetz, S.; Callaghan, R.; Gros, P.; McNaughton, P. A.; Higgins, C. F. Protein kinase C-mediated phosphorylation does not regulate drug transport by the human multidrug resistance P-glycoprotein. J. Biol. Chem., 1996, 271, 13668-13674.
30. Hardy, S. P.; Goodfellow, H. R.; Valverde, M. A.; Gill, D. R.; Sepulveda, V.; Higgins, C. F. Protein kinase C-mediated phosphorylation of the human multidrug resistance P-glycoprotein regulates cell volume-activated chloride channels. EMBO J., 1995, 14, 68-75.
31. Idriss, H.; Urquidi, V.; Basavappa, S. Selective modulation of Pglycoprotein's ATPase and anion efflux regulation activities with PKC alpha and PKC epsilon in Sf9 cells. Cancer Chemother. Pharmacol., 2000, 46, 287-292.
32. Idriss, H. T.; Hannun, Y. A.; Boulpaep, E.; Basavappa, S. Regulation of volume-activated chloride channels by Pglycoprotein: phosphorylation has the final say. J. Physiol., 2000, 524(Pt 3), 629-636.
33. Lelong, I. H.; Cardarelli, C. O.; Gottesman, M. M.; Pastan, I. GTPstimulated phosphorylation of P-glycoprotein in transporting vesicles from KB-V1 multidrug resistant cells. Biochemistry, 1994, 33, 8921-8929.
34. Lelong-Rebel, I. H.; Cardarelli, C. O. Differential phosphorylation patterns of P-glycoprotein reconstituted into a proteoliposome system: insight into additional unconventional phosphorylation sites. Anticancer Res., 2005, 25, 3925-3935.
35. Lelong-Rebel, I. H.; Rebel, G.; Cardarelli, C. O.; Pastan, I.; Gottesman, M. M. Modulation by the ATP/GTP ratio of the phosphorylation level of P-glycoprotein and of various plasma membrane proteins of KB-V1 multidrug resistant cells. Anticancer Res., 2003, 23, 2363-2375.
36. Ma, L. D.; Marquardt, D.; Takemoto, L.; Center, M. S. Analysis of P-glycoprotein phosphorylation in HL60 cells isolated for resistance to vincristine. J. Biol. Chem., 1991, 266, 5593-5599.
37. Masanek, U.; Stammler, G.; Volm, M. Modulation of multidrug resistance in human ovarian cancer cell lines by inhibition of Pglycoprotein 170 and PKC isoenzymes with antisense oligonucleotides. J. Exp. Ther. Oncol., 2002, 2, 37-41.
38. Mellado, W.; Horwitz, S. B. Phosphorylation of the multidrug resistance associated glycoprotein. Biochemistry, 1987, 26, 6900-6904.
39. Orr, G. A.; Han, E. K.; Browne, P. C.; Nieves, E.; O'Connor, B. M.; Yang, C. P.; Horwitz, S. B. Identification of the major phosphorylation domain of murine mdr1b P-glycoprotein. Analysis of the protein kinase A and protein kinase C phosphorylation sites. J. Biol. Chem., 1993, 268, 25054-25064.
40. Sachs, C. W.; Ballas, L. M.; Mascarella, S. W.; Safa, A. R.; Lewin, A. H.; Loomis, C.; Carroll, F. I.; Bell, R. M.; Fine, R. L. Effects of sphingosine stereoisomers on P-glycoprotein phosphorylation and vinblastine accumulation in multidrug-resistant MCF-7 cells. Biochem. Pharmacol., 1996, 52, 603-612.
41. Staats, J.; Marquardt, D.; Center, M. S. Characterization of a membrane-associated protein kinase of multidrug-resistant HL60 cells which phosphorylates P-glycoprotein. J. Biol. Chem., 1990, 265, 4084.
42. Szabo, K.; Bakos, E.; Welker, E.; Muller, M.; Goodfellow, H. R.; Higgins, C. F.; Varadi, A.; Sarkadi, B. Phosphorylation site mutations in the human multidrug transporter modulate its drugstimulated ATPase activity. J. Biol. Chem., 1997, 272, 23165-23171.
43. Vanoye, C. G.; Castro, A. F.; Pourcher, T.; Reuss, L.; Altenberg, G. A. Phosphorylation of P-glycoprotein by PKA and PKC modulates swelling-activated Cl-currents. Am. J. Physiol., 1999, 276, C370.
44. Brendel, C.; Scharenberg, C.; Dohse, M.; Robey, R. W.; Bates, S. E.; Shukla, S.; Ambudkar, S. V.; Wang, Y.; Wennemuth, G.; Burchert, A.; Boudriot, U.; Neubauer, A. Imatinib mesylate and nilotinib (AMN107) exhibit high-affinity interaction with ABCG2 on primitive hematopoietic stem cells. Leukemia, 2007, 21, 1267-1275.
45. Ozvegy-Laczka, C.; Cserepes, J.; Elkind, N. B.; Sarkadi, B. Tyrosine kinase inhibitor resistance in cancer: role of ABC multidrug transporters. Drug Resist. Updat, 2005, 8, 15-26.
46. Shi, Z.; Peng, X. X.; Kim, I. W.; Shukla, S.; Si, Q. S.; Robey, R. W.; Bates, S. E.; Shen, T.; Ashby, C. R., Jr.; Fu, L. W.; Ambudkar, S. V.; Chen, Z. S. Erlotinib (Tarceva, OSI-774) antagonizes ATPbinding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance. Cancer Res., 2007, 67, 11012-11020.
47. Shi, Z.; Tiwari, A. K.; Shukla, S.; Robey, R. W.; Kim, I. W.; Parmar, S.; Bates, S. E.; Si, Q. S.; Goldblatt, C. S.; Abraham, I.; Fu, L. W.; Ambudkar, S. V.; Chen, Z. S. Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478. Biochem. Pharmacol., 2009, 77, 781-793.
48. Shukla, S.; Robey, R. W.; Bates, S. E.; Ambudkar, S. V. Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2. Drug Metab. Dispos., 2009, 37, 359-365.
49. Richter, S.; Geldner, N.; Schrader, J.; Wolters, H.; Stierhof, Y. D.; Rios, G.; Koncz, C.; Robinson, D. G.; Jurgens, G. Functional diversification of closely related ARF-GEFs in protein secretion and recycling. Nature, 2007, 448, 488-492.
50. Bowring, C. E.; Llewellyn, D. H. Differences in HAC1 mRNA processing and translation between yeast and mammalian cells indicate divergence of the eukaryotic ER stress response. Biochem. Biophys. Res. Commun., 2001, 287, 789-800.
51. Morreale, G.; Conforti, L.; Coadwell, J.; Wilbrey, A. L.; Coleman, M. P. Evolutionary divergence of valosin-containing protein/cell division cycle protein 48 binding interactions among endoplasmic reticulum-associated degradation proteins. FEBS J., 2009, 276, 1208-1220.
52. Li, Y.; Salter-Cid, L.; Vitiello, A.; Preckel, T.; Lee, J. D.; Angulo, A.; Cai, Z.; Peterson, P. A.; Yang, Y. Regulation of transporter associated with antigen processing by phosphorylation. J. Biol. Chem., 2000, 275, 24130-24135.
53. Hipfner, D. R.; Gauldie, S. D.; Deeley, R. G.; Cole, S. P. Detection of the M(r) 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. Cancer Res., 1994, 54, 5788.
54. Slovak, M. L.; Ho, J. P.; Bhardwaj, G.; Kurz, E. U.; Deeley, R. G.; Cole, S. P. Localization of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69AR human tumor cell lines. Cancer Res., 1993, 53, 3221-3225.
55. Cole, S. P.; Bhardwaj, G.; Gerlach, J. H.; Mackie, J. E.; Grant, C. E.; Almquist, K. C.; Stewart, A. J.; Kurz, E. U.; Duncan, A. M.; Deeley, R. G. Overexpression of a transporter gene in a multidrugresistant human lung cancer cell line. Science, 1992, 258, 1650-1654.
56. Keitel, V.; Nies, A. T.; Brom, M.; Hummel-Eisenbeiss, J.; Spring, H.; Keppler, D. A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2) Am. J. Physiol. Gastrointest. Liver Physiol., 2003, 284, G165-174.
57. Keppler, D.; Konig, J. Hepatic secretion of conjugated drugs and endogenous substances. Semin Liver Dis., 2000, 20, 265-272.
58. Ito, K.; Wakabayashi, T.; Horie, T. Mrp2/Abcc2 transport activity is stimulated by protein kinase Calpha in a baculo virus coexpression. system. Life Sci., 2005, 77, 539-550.
59. Minami, S.; Ito, K.; Honma, M.; Ikebuchi, Y.; Anzai, N.; Kanai, Y.; Nishida, T.; Tsukita, S.; Sekine, S.; Horie, T.; Suzuki, H. Posttranslational regulation of Abcc2 expression by SUMOylation system. Am. J. Physiol. Gastrointest. Liver Physiol., 2009, 296, G406-413.
60. Wimmer, R.; Hohenester, S.; Pusl, T.; Denk, G. U.; Rust, C.; Beuers, U. Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKC alpha-/PKA-dependent mechanism in rat liver. Gut, 2008, 57, 1448-1454.
61. Dean, M.; Hamon, Y.; Chimini, G. The human ATP-binding cassette (ABC) transporter superfamily. J. Lipid Res., 2001, 42, 1007.
62. Tabcharani, J. A.; Chang, X. B.; Riordan, J. R.; Hanrahan, J. W. Phosphorylation-regulated Cl-channel in CHO cells stably expressing the cystic fibrosis gene. Nature, 1991, 352, 628-631.
63. Picciotto, M. R.; Cohn, J. A.; Bertuzzi, G.; Greengard, P.; Nairn, A. C. Phosphorylation of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem., 1992, 267, 12742-12752.
64. Cheng, S. H.; Rich, D. P.; Marshall, J.; Gregory, R. J.; Welsh, M. J.; Smith, A. E. Phosphorylation of the R domain by cAMPdependent protein kinase regulates the CFTR chloride channel. Cell, 1991, 66, 1027-1036.
65. Aleksandrov, A. A.; Aleksandrov, L. A.; Riordan, J. R. CFTR (ABCC7) is a hydrolyzable-ligand-gated channel. Pflugers. Arch., 2007, 453, 693-702.
66. Gadsby, D. C.; Vergani, P.; Csanady, L. The ABC protein turned chloride channel whose failure causes cystic fibrosis. Nature, 2006, 440, 477-483.
67. Hegedus, T.; Aleksandrov, A.; Mengos, A.; Cui, L.; Jensen, T. J.; Riordan, J. R. Role of individual R domain phosphorylation sites in CFTR regulation by protein kinase A. Biochim. Biophys. Acta, 2009, 1788, 1341-1349.
68. Hegedus, T.; Serohijos, A. W.; Dokholyan, N. V.; He, L.; Riordan, J. R. Computational studies reveal phosphorylation-dependent changes in the unstructured R domain of CFTR. J. Mol. Biol., 2008, 378, 1052-1063.
69. Seibert, F. S.; Chang, X. B.; Aleksandrov, A. A.; Clarke, D. M.; Hanrahan, J. W.; Riordan, J. R. Influence of phosphorylation by protein kinase A on CFTR at the cell surface and endoplasmic reticulum. Biochim. Biophys. Acta, 1999, 1461, 275-283.
70. Zhang, L.; Aleksandrov, L. A.; Zhao, Z.; Birtley, J. R.; Riordan, J. R.; Ford, R. C. Architecture of the cystic fibrosis transmembrane conductance regulator protein and structural changes associated with phosphorylation and nucleotide binding. J. Struct. Biol., 2009, 167, 242-251.
71. Gadsby, D. C.; Nairn, A. C. Control of CFTR channel gating by phosphorylation and nucleotide hydrolysis. Physiol. Rev., 1999, 79, S77.
72. Chappe, V.; Hinkson, D. A.; Zhu, T.; Chang, X. B.; Riordan, J. R.; Hanrahan, J. W. Phosphorylation of protein kinase C sites in NBD1 and the R domain control CFTR channel activation by PKA. J. Physiol., 2003, 548, 39-52.
73. Csanady, L.; Chan, K. W.; Nairn, A. C.; Gadsby, D. C. Functional roles of nonconserved structural segments in CFTR's NH2-terminal nucleotide binding domain. J. Gen. Physiol., 2005, 125, 43-55.
74. Lewis, H. A.; Buchanan, S. G.; Burley, S. K.; Conners, K.; Dickey, M.; Dorwart, M.; Fowler, R.; Gao, X.; Guggino, W. B.; Hendrickson, W. A.; Hunt, J. F.; Kearins, M. C.; Lorimer, D.; Maloney, P. C.; Post, K. W.; Rajashankar, K. R.; Rutter, M. E.; Sauder, J. M.; Shriver, S.; Thibodeau, P. H.; Thomas, P. J.; Zhang, M.; Zhao, X.; Emtage, S. Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. EMBO J., 2004, 23, 282-292.
75. Becq, F.; Jensen, T. J.; Chang, X. B.; Savoia, A.; Rommens, J. M.; Tsui, L. C.; Buchwald, M.; Riordan, J. R.; Hanrahan, J. W. Phosphatase inhibitors activate normal and defective CFTR chloride channels. Proc. Natl. Acad. Sci. USA, 1994, 91(19), 9160-9164.
76. Chang, X. B.; Tabcharani, J. A.; Hou, Y. X.; Jensen, T. J.; Kartner, N.; Alon, N.; Hanrahan, J. W.; Riordan, J. R. Protein kinase A (PKA) still activates CFTR chloride channel after mutagenesis of all 10 PKA consensus phosphorylation sites. J. Biol. Chem., 1993, 268, 11304-11311.
77. Chappe, V.; Hinkson, D. A.; Howell, L. D.; Evagelidis, A.; Liao, J.; Chang, X. B.; Riordan, J. R.; Hanrahan, J. W. Stimulatory and inhibitory protein kinase C consensus sequences regulate the cystic fibrosis transmembrane conductance regulator. Proc. Natl. Acad. Sci. USA, 2004, 101, 390-395.
78. Dulhanty, A. M.; Riordan, J. R. Phosphorylation by cAMPdependent protein kinase causes a conformational change in the R domain of the cystic fibrosis transmembrane conductance regulator. Biochemistry, 1994, 33, 4072.
79. Mathews, C. J.; Tabcharani, J. A.; Chang, X. B.; Jensen, T. J.; Riordan, J. R.; Hanrahan, J. W. Dibasic protein kinase A sites regulate bursting rate and nucleotide sensitivity of the cystic fibrosis transmembrane conductance regulator chloride channel. J. Physiol., 1998, 508(Pt 2), 365-377.
80. Seibert, F. S.; Tabcharani, J. A.; Chang, X. B.; Dulhanty, A. M.; Mathews, C.; Hanrahan, J. W.; Riordan, J. R. cAMP-dependent protein kinase-mediated phosphorylation of cystic fibrosis transmembrane conductance regulator residue Ser-753 and its role in channel activation. J. Biol. Chem., 1995, 270, 2158-2162.
81. Broughman, J. R.; Sun, L.; Umar, S.; Sellin, J. H.; Morris, A. P. Chronic PKC-beta2 activation in HT-29 Cl.19a colonocytes prevents cAMP-mediated ion secretion by inhibiting apical membrane CFTR targeting. Am. J. Physiol. Gastrointest. Liver Physiol., 2006, 291, G331-334.
82. Sun, F.; Hug, M. J.; Bradbury, N. A.; Frizzell, R. A. Protein kinase A associates with cystic fibrosis transmembrane conductance regulator via an interaction with ezrin. J. Biol. Chem., 2000, 275, 14360-14366.
83. Thelin, W. R.; Kesimer, M.; Tarran, R.; Kreda, S. M.; Grubb, B. R.; Sheehan, J. K.; Stutts, M. J.; Milgram, S. L. The cystic fibrosis transmembrane conductance regulator is regulated by a direct interaction with the protein phosphatase 2A. J. Biol. Chem., 2005, 280, 41512-41520.
84. Kongsuphol, P.; Cassidy, D.; Hieke, B.; Treharne, K. J.; Schreiber, R.; Mehta, A.; Kunzelmann, K. Mechanistic insight into control of CFTR by AMPK. J. Biol. Chem., 2009, 284, 5645-5653.
85. Pagano, M. A.; Arrigoni, G.; Marin, O.; Sarno, S.; Meggio, F.; Treharne, K. J.; Mehta, A.; Pinna, L. A. Modulation of protein kinase CK2 activity by fragments of CFTR encompassing F508 may reflect functional links with cystic fibrosis pathogenesis. Biochemistry, 2008, 47, 7925-7936.
86. Treharne, K. J.; Crawford, R. M.; Xu, Z.; Chen, J. H.; Best, O. G.; Schulte, E. A.; Gruenert, D. C.; Wilson, S. M.; Sheppard, D. N.; Kunzelmann, K.; Mehta, A. Protein kinase CK2, cystic fibrosis transmembrane conductance regulator, and the deltaF508 mutation: F508 deletion disrupts a kinase-binding site. J. Biol. Chem., 2007, 282, 10804-10813.
87. King, J. D., Jr.; Fitch, A. C.; Lee, J. K.; McCane, J. E.; Mak, D. O.; Foskett, J. K.; Hallows, K. R. AMP-activated protein kinase phosphorylation of the R domain inhibits PKA stimulation of CFTR. Am. J. Physiol. Cell Physiol., 2009, 297, C94-101.
88. Csanady, L.; Seto-Young, D.; Chan, K. W.; Cenciarelli, C.; Angel, B. B.; Qin, J.; McLachlin, D. T.; Krutchinsky, A. N.; Chait, B. T.; Nairn, A. C.; Gadsby, D. C. Preferential phosphorylation of Rdomain Serine 768 dampens activation of CFTR channels by PKA. J. Gen. Physiol., 2005, 125, 171-186.
89. Dahan, D.; Evagelidis, A.; Hanrahan, J. W.; Hinkson, D. A.; Jia, Y.; Luo, J.; Zhu, T. Regulation of the CFTR channel by phosphorylation.Pflugers Arch., 2001, 443 (Suppl 1), S92.
90. Ostedgaard, L. S.; Baldursson, O.; Welsh, M. J. Regulation of the cystic fibrosis transmembrane conductance regulator Cl-channel by its R domain. J. Biol. Chem., 2001, 276, 7689-7692.
91. Baker, J. M.; Hudson, R. P.; Kanelis, V.; Choy, W. Y.; Thibodeau, P. H.; Thomas, P. J.; Forman-Kay, J. D. CFTR regulatory region interacts with NBD1 predominantly via multiple transient helices. Nat. Struct. Mol. Biol., 2007, 14, 738.
92. Kanelis, V.; Hudson, R. P.; Thibodeau, P. H.; Thomas, P. J.; Forman-Kay, J. D. NMR evidence for differential phosphorylationdependent interactions in WT and DeltaF508 CFTR. EMBO. J., 2010, 29, 263-277.
93. Dean, M.; Rzhetsky, A.; Allikmets, R. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res., 2001, 11, 1156-1166.
94. Babenko, A. P.; Aguilar-Bryan, L.; Bryan, J. A view of sur/KIR6.X, KATP channels. Annu. Rev. Physiol., 1998, 60, 667-687.
95. Babenko, A. P.; Gonzalez, G.; Aguilar-Bryan, L.; Bryan, J. Reconstituted human cardiac KATP channels: functional identity with the native channels from the sarcolemma of human ventricular cells. Circ. Res., 1998, 83, 1132-1143.
96. Beguin, P.; Nagashima, K.; Nishimura, M.; Gonoi, T.; Seino, S. PKA-mediated phosphorylation of the human K(ATP) channel: separate roles of Kir6.2 and SUR1 subunit phosphorylation. EMBO J., 1999, 18, 4722.
97. Lin, Y. F.; Chai, Y. Functional modulation of the ATP-sensitive potassium channel by extracellular signal-regulated kinasemediated phosphorylation. Neuroscience, 2008, 152, 371-380.
98. Lin, Y. F.; Jan, Y. N.; Jan, L. Y. Regulation of ATP-sensitive potassium channel function by protein kinase A-mediated phosphorylation in transfected HEK293 cells. EMBO J.,2000, 19, 942-955.
99. Quinn, K. V.; Giblin, J. P.; Tinker, A. Multisite phosphorylation mechanism for protein kinase A activation of the smooth muscle ATP-sensitive K+ channel. Circ. Res., 2004, 94, 1359-1366.
100. Ribalet, B.; John, S. A.; Weiss, J. N. Regulation of cloned ATPsensitive K channels by phosphorylation, MgADP, and phosphatidylinositol bisphosphate (PIP(2)): a study of channel rundown and reactivation. J. Gen. Physiol., 2000, 116, 391-410.
101. Shi, Y.; Chen, X.; Wu, Z.; Shi, W.; Yang, Y.; Cui, N.; Jiang, C.; Harrison, R. W. cAMP-dependent protein kinase phosphorylation produces interdomain movement in SUR2B leading to activation of the vascular KATP channel.J. Biol. Chem., 2008, 283, 7523-7530.
102. Yang, Y.; Shi, Y.; Guo, S.; Zhang, S.; Cui, N.; Shi, W.; Zhu, D.; Jiang, C. PKA-dependent activation of the vascular smooth muscle isoform of KATP channels by vasoactive intestinal polypeptide and its effect on relaxation of the mesenteric resistance artery. Biochim. Biophys. Acta, 2008, 1778, 88-96.
103. Shi, Y.; Wu, Z.; Cui, N.; Shi, W.; Yang, Y.; Zhang, X.; Rojas, A.; Ha, B. T.; Jiang, C. PKA phosphorylation of SUR2B subunit underscores vascular KATP channel activation by beta-adrenergic receptors. Am. J. Physiol., 2007, 293, R1205-1214.
104. Tanaka, A. R.; Tanabe, K.; Morita, M.; Kurisu, M.; Kasiwayama, Y.; Matsuo, M.; Kioka, N.; Amachi, T.; Imanaka, T.; Ueda, K. ATP binding/hydrolysis by and phosphorylation of peroxisomal ATP-binding cassette proteins PMP70 (ABCD3) and adrenoleukodystrophy protein (ABCD1). J. Biol. Chem., 2002, 277, 40142-40147.
105. Xie, Y.; Xu, K.; Linn, D. E.; Yang, X.; Guo, Z.; Shimelis, H.; Nakanishi, T.; Ross, D. D.; Chen, H.; Fazli, L.; Gleave, M. E.; Qiu, Y. The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells. J. Biol. Chem., 2008, 283, 3349-3356.
106. Kiran, M. D.; Akiyoshi, D. E.; Giacometti, A.; Cirioni, O.; Scalise, G.; Balaban, N. OpuC--an ABC transporter that is associated with Staphylococcus aureus pathogenesis. Int. J. Artif. Organs, 2009, 32, 600-610.
107. Colicchio, R.; Ricci, S.; Lamberti, F.; Pagliarulo, C.; Pagliuca, C.; Braione, V.; Braccini, T.; Tala, A.; Montanaro, D.; Tripodi, S.; Cintorino, M.; Troncone, G.; Bucci, C.; Pozzi, G.; Bruni, C. B.; Alifano, P.; Salvatore, P. The meningococcal ABC-Type L glutamate transporter GltT is necessary for the development of experimental meningitis in mice. Infect. Immun., 2009, 77, 3578-3587.
108. Lamarche, M. G.; Wanner, B. L.; Crepin, S.; Harel, J. The phosphate regulon and bacterial virulence: a regulatory network connecting phosphate homeostasis and pathogenesis. FEMS Microbiol. Rev., 2008, 32, 461-473.
109. Mishra, N. N.; Prasad, T.; Sharma, N.; Payasi, A.; Prasad, R.; Gupta, D. K.; Singh, R. Pathogenicity and drug resistance in Candida albicans and other yeast species. A review. Acta Microbiol. Immunol. Hung., 2007, 54, 201-235.
110. Niimi, M.; Tanabe, K.; Wada, S.; Yamazaki, A.; Uehara, Y.; Niimi, K.; Lamping, E.; Holmes, A. R.; Monk, B. C.; Cannon, R. D. [ABC transporters of pathogenic fungi: recent advances in functional analyses]. Nippon Ishinkin Gakkai Zasshi, 2005, 46, 249-260.
111. Upcroft, P. Multiple drug resistance in the pathogenic protozoa. Acta Trop., 1994, 56, 195-212.
112. Del Sorbo, G.; Schoonbeek, H.; De Waard, M. A. Fungal transporters involved in efflux of natural toxic compounds and fungicides. Fungal Genet. Biol., 2000, 30, 1-15.
113. Davidson, A. L.; Chen, J. ATP-binding cassette transporters in bacteria. Annu. Rev. Biochem., 2004, 73, 241-261.
114. Raetz, C. R.; Reynolds, C. M.; Trent, M. S.; Bishop, R. E. Lipid A modification systems in gram-negative bacteria. Annu. Rev. Biochem., 2007, 76, 295-329.
115. Cai, J.; Gros, P. Overexpression, purification, and functional characterization of ATP-binding cassette transporters in the yeast, Pichia pastoris. Biochim. Biophys. Acta, 2003, 1610, 63-76.
116. Sipos, G.; Kuchler, K. Fungal ATP-binding cassette (ABC) transporters in drug resistance & detoxification. Curr. Drug Targets, 2006, 7, 471-481.
117. Albuquerque, C. P.; Smolka, M. B.; Payne, S. H.; Bafna, V.; Eng, J.; Zhou, H. A multidimensional chromatography technology for in-depth phosphoproteome analysis. Mol. Cell Proteomics., 2008, 7, 1389-1396.
118. Gruhler, A.; Olsen, J. V.; Mohammed, S.; Mortensen, P.; Faergeman, N. J.; Mann, M.; Jensen, O. N. Quantitative phosphoproteomics applied to the yeast pheromone signaling pathway. Mol. Cell Proteomics., 2005, 4, 310-327.
119. Li, X.; Gerber, S. A.; Rudner, A. D.; Beausoleil, S. A.; Haas, W.; Villen, J.; Elias, J. E.; Gygi, S. P. Large-scale phosphorylation analysis of alpha-factor-arrested Saccharomyces cerevisiae. J. Proteome. Res., 2007, 6, 1190-1197.
120. Smolka, M. B.; Albuquerque, C. P.; Chen, S. H.; Zhou, H. Proteome-wide identification of in vivo targets of DNA damage checkpoint kinases. Proc. Natl. Acad. Sci. USA, 2007, 104, 10364-10369.
121. Curry, J. M.; Whalan, R.; Hunt, D. M.; Gohil, K.; Strom, M.; Rickman, L.; Colston, M. J.; Smerdon, S. J.; Buxton, R. S. An ABC transporter containing a forkhead-associated domain interacts with a serine-threonine protein kinase and is required for growth of Mycobacterium tuberculosis in mice. Infect. Immun., 2005, 73, 4471-4477.
122. Kelm, K. B.; Huyer, G.; Huang, J. C.; Michaelis, S. The internalization of yeast Ste6p follows an ordered series of events involving phosphorylation, ubiquitination, recognition and endocytosis. Traffic, 2004, 5, 165-180.
123. Kolling, R. Mutations affecting phosphorylation, ubiquitination and turnover of the ABC-transporter Ste6. FEBS Lett., 2002, 531, 548-552.
124. Paumi, C. M.; Chuk, M.; Chevelev, I.; Stagljar, I.; Michaelis, S. Negative regulation of the yeast ABC transporter Ycf1p by phosphorylation within its N-terminal extension. J. Biol. Chem., 2008, 283, 27079-27088.
125. Subba Rao, G.; Bachhawat, A. K.; Gupta, C. M. Two-hybrid-based analysis of protein-protein interactions of the yeast multidrug resistance protein, Pdr5p. Funct. Integr. Genomics., 2002, 1, 357-366.
126. Chen, X. J. Activity of the Kluyveromyces lactis Pdr5 multidrug transporter is modulated by the Sit4 protein phosphatase. J. Bacteriol., 2001, 183, 3939-3948.
127. Eraso, P.; Martinez-Burgos, M.; Falcon-Perez, J. M.; Portillo, F.; Mazon, M. J. Ycf1-dependent cadmium detoxification by yeast requires phosphorylation of residues Ser908 and Thr911. FEBS Lett., 2004, 577, 322-326.
128. Molle, V.; Soulat, D.; Jault, J. M.; Grangeasse, C.; Cozzone, A. J.; Prost, J. F. Two FHA domains on an ABC transporter, Rv1747, mediate its phosphorylation by PknF, a Ser/Thr protein kinase from Mycobacterium tuberculosis. FEMSMicrobiol. Lett., 2004, 234, 215-223.
129. Wada, S.; Tanabe, K.; Yamazaki, A.; Niimi, M.; Uehara, Y.; Niimi, K.; Lamping, E.; Cannon, R. D.; Monk, B. C. Phosphorylation of candida glabrata ATP-binding cassette transporter Cdr1p regulates drug efflux activity and ATPase stability. J. Biol. Chem., 2005, 280, 94-103.
130. Rogers, L. D.; Foster, L. J. Phosphoproteomics--finally fulfilling the promise.? Mol. Biosyst., 2009, 5, 1122.
131. Chen, G.; Pramanik, B. N. Application of LC/MS to proteomics studies: current status and future prospects. Drug Discov. Today, 2009, 14, 465-471.
132. Brooks-Wilson, A.; Marcil, M.; Clee, S. M.; Zhang, L. H.; Roomp, K.; van Dam, M.; Yu, L.; Brewer, C.; Collins, J. A.; Molhuizen, H. O.; Loubser, O.; Ouelette, B. F.; Fichter, K.; Ashbourne-Excoffon, K. J.; Sensen, C. W.; Scherer, S.; Mott, S.; Denis, M.; Martindale, D.; Frohlich, J.; Morgan, K.; Koop, B.; Pimstone, S.; Kastelein, J. J.; Genest, J., Jr.; Hayden, M. R. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet., 1999, 22, 336-345.
133. Allikmets, R.; Shroyer, N. F.; Singh, N.; Seddon, J. M.; Lewis, R. A.; Bernstein, P. S.; Peiffer, A.; Zabriskie, N. A.; Li, Y.; Hutchinson, A.; Dean, M.; Lupski, J. R.; Leppert, M. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science, 1997, 277, 1805-1807.
134. Powis, S. J.; Howard, J. C.; Butcher, G. W. The major histocompatibility complex class II-linked cim locus controls the kinetics of intracellular transport of a classical class I molecule. J. Exp. Med., 1991, 173, 913.
135. Momburg, F.; Roelse, J.; Neefjes, J.; Hammerling, G. J. Peptide transporters and antigen processing. Behring Inst Mitt., 1994, (94), 26-36.
136. Strautnieks, S. S.; Bull, L. N.; Knisely, A. S.; Kocoshis, S. A.; Dahl, N.; Arnell, H.; Sokal, E.; Dahan, K.; Childs, S.; Ling, V.; Tanner, M. S.; Kagalwalla, A. F.; Nemeth, A.; Pawlowska, J.; Baker, A.; Mieli-Vergani, G.; Freimer, N. B.; Gardiner, R. M.; Thompson, R. J. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat. Genet., 1998, 20, 233-238.
137. Allikmets, R.; Raskind, W. H.; Hutchinson, A.; Schueck, N. D.; Dean, M.; Koeller, D. M. Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A). Hum. Mol. Genet., 1999, 8, 743.
138. Paulusma, C. C.; Kool, M.; Bosma, P. J.; Scheffer, G. L.; ter Borg, F.; Scheper, R. J.; Tytgat, G. N.; Borst, P.; Baas, F.; Oude Elferink, R. P. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology, 1997, 25, 1539-1542.
139. Ringpfeil, F.; Lebwohl, M. G.; Christiano, A. M.; Uitto, J. Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc. Natl. Acad. Sci. USA, 2000, 97, 6001-6006.
140. Riordan, J. R.; Rommens, J. M.; Kerem, B.; Alon, N.; Rozmahel, R.; Grzelczak, Z.; Zielenski, J.; Lok, S.; Plavsic, N.; Chou, J. L. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science, 1989, 245, 1066-1073.
141. Nestorowicz, A.; Wilson, B. A.; Schoor, K. P.; Inoue, H.; Glaser, B.; Landau, H.; Stanley, C. A.; Thornton, P. S.; Clement, J. P. t.; Bryan, J.; Aguilar-Bryan, L.; Permutt, M. A. Mutations in the sulonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews. Hum. Mol. Genet., 1996, 5, 1813-1822.
142. Mosser, J.; Lutz, Y.; Stoeckel, M. E.; Sarde, C. O.; Kretz, C.; Douar, A. M.; Lopez, J.; Aubourg, P.; Mandel, J. L. The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein. Hum. Mol. Genet., 1994, 3, 265-271.
143. Berge, K. E.; Tian, H.; Graf, G. A.; Yu, L.; Grishin, N. V.; Schultz, J.; Kwiterovich, P.; Shan, B.; Barnes, R.; Hobbs, H. H. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science, 2000, 290, 1771-1775.
144. Doyle, L. A.; Yang, W.; Abruzzo, L. V.; Krogmann, T.; Gao, Y.; Rishi, A. K.; Ross, D. D. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA, 1998, 95, 15665.
145. Chen, C. J.; Chin, J. E.; Ueda, K.; Clark, D. P.; Pastan, I.; Gottesman, M. M.; Roninson, I. B. Internal duplication and homology with bacterial transport proteins in the mdr1 (Pglycoprotein) gene from multidrug-resistant human cells. Cell, 1986, 47, 381-389.
146. Gottesman, M. M.; Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem., 1993, 62, 385-427.
147. Olsen, J. V.; Blagoev, B.; Gnad, F.; Macek, B.; Kumar, C.; Mortensen, P.; Mann, M. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell, 2006, 127, 635-648.
148. Rikova, K.; Guo, A.; Zeng, Q.; Possemato, A.; Yu, J.; Haack, H.; Nardone, J.; Lee, K.; Reeves, C.; Li, Y.; Hu, Y.; Tan, Z.; Stokes, M.; Sullivan, L.; Mitchell, J.; Wetzel, R.; Macneill, J.; Ren, J. M.; Yuan, J.; Bakalarski, C. E.; Villen, J.; Kornhauser, J. M.; Smith, B.; Li, D.; Zhou, X.; Gygi, S. P.; Gu, T. L.; Polakiewicz, R. D.; Rush, J.; Comb, M. J. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell, 2007, 131, 1190-1230.
149. Dephoure, N.; Zhou, C.; Villen, J.; Beausoleil, S. A.; Bakalarski, C. E.; Elledge, S. J.; Gygi, S. P. A quantitative atlas of mitotic phosphorylation. Proc. Natl. Acad. Sci. USA, 2008, 105, 10762-10767.
150. Hornbeck, P.V.; Chabra, I.; Kornhauser, J.M.; Skrzypek, E.; Zhang, B. PhosphoSite: A bioinformatics resource dedicated to physiological protein phosphorylation. Proteomics, 2004, 4(6), 1551-1561.
151. Tao, W. A.; Wollscheid, B.; O'Brien, R.; Eng, J. K.; Li, X. J.; Bodenmiller, B.; Watts, J. D.; Hood, L.; Aebersold, R. Quantitative phosphoproteome analysis using a dendrimer conjugation chemistry and tandem mass spectrometry. Nat. Methods, 2005, 2, 591-598.
152. Imami, K.; Sugiyama, N.; Kyono, Y.; Tomita, M.; Ishihama, Y. Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column. Anal. Sci., 2008, 24, 161-166.
153. Beausoleil, S. A.; Jedrychowski, M.; Schwartz, D.; Elias, J. E.; Villen, J.; Li, J.; Cohn, M. A.; Cantley, L. C.; Gygi, S. P. Largescale characterization of HeLa cell nuclear phosphoproteins. Proc. Natl. Acad. Sci. USA, 2004, 101, 12130-12135.
154. Daub, H.; Olsen, J. V.; Bairlein, M.; Gnad, F.; Oppermann, F. S.; Korner, R.; Greff, Z.; Keri, G.; Stemmann, O.; Mann, M. Kinaseselective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. Mol. Cell, 2008, 31, 438-448.
155. Mayya, V.; Lundgren, D. H.; Hwang, S. I.; Rezaul, K.; Wu, L.; Eng, J. K.; Rodionov, V.; Han, D. K. Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci. Signal, 2009, 2, ra46.
156. Gauci, S.; Helbig, A. O.; Slijper, M.; Krijgsveld, J.; Heck, A. J.; Mohammed, S. Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal. Chem., 2009, 81, 4493-4501.
157. Brill, L. M.; Motamedchaboki, K.; Wu, S.; Wolf, D. A. Comprehensive proteomic analysis of Schizosaccharomyces pombe by two-dimensional HPLC-tandem mass spectrometry. Methods, 2009, 48, 311-319.
158. Brill, L. M.; Xiong, W.; Lee, K. B.; Ficarro, S. B.; Crain, A.; Xu, Y.; Terskikh, A.; Snyder, E. Y.; Ding, S. Phosphoproteomic analysis of human embryonic stem cells. Cell Stem Cell, 2009, 5, 204-213.
159. Jorgensen, C.; Sherman, A.; Chen, G. I.; Pasculescu, A.; Poliakov, A.; Hsiung, M.; Larsen, B.; Wilkinson, D. G.; Linding, R.; Pawson, T. Cell-specific information processing in segregating populations of Eph receptor ephrin-expressing cells. Science, 2009, 326, 1502-1509.
160. Guo, A.; Villen, J.; Kornhauser, J.; Lee, K. A.; Stokes, M. P.; Rikova, K.; Possemato, A.; Nardone, J.; Innocenti, G.; Wetzel, R.; Wang, Y.; MacNeill, J.; Mitchell, J.; Gygi, S. P.; Rush, J.; Polakiewicz, R. D.; Comb, M. J. Signaling networks assembled by oncogenic EGFR and c-Met. Proc. Natl. Acad. Sci. USA, 2008, 105, 692-697.
161. Oppermann, F. S.; Gnad, F.; Olsen, J. V.; Hornberger, R.; Greff, Z.; Keri, G.; Mann, M.; Daub, H. Large-scale proteomics analysis of the human kinome. Mol. Cell Proteomics, 2009, 8, 1751-1764.
162. Thingholm, T. E.; Larsen, M. R.; Ingrell, C. R.; Kassem, M.; Jensen, O. N. TiO(2)-based phosphoproteomic analysis of the plasma membrane and the effects of phosphatase inhibitor treatment. J. Proteome Res., 2008, 7, 3304-3313.
163. Villen, J.; Beausoleil, S. A.; Gerber, S. A.; Gygi, S. P. Large-scale phosphorylation analysis of mouse liver. Proc. Natl. Acad. Sci. USA, 2007, 104, 1488-1493.
164. Sui, S.; Wang, J.; Yang, B.; Song, L.; Zhang, J.; Chen, M.; Liu, J.; Lu, Z.; Cai, Y.; Chen, S.; Bi, W.; Zhu, Y.; He, F.; Qian, X. Phosphoproteome analysis of the human Chang liver cells using SCX and a complementary mass spectrometric strategy. Proteomics, 2008, 8, 2024-2434.
165. Yu, L. R.; Zhu, Z.; Chan, K. C.; Issaq, H. J.; Dimitrov, D. S.; Veenstra, T. D. Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra. J. Proteome Res., 2007, 6, 4150-4162.
166. Townsend, R. R.; Lipniunas, P. H.; Tulk, B. M.; Verkman, A. S. Identification of protein kinase A phosphorylation sites on NBD1 and R domains of CFTR using electrospray mass spectrometry with selective phosphate ion monitoring. Protein Sci., 1996, 5, 1865-1873.
167. Wang, Y.; Du, D.; Fang, L.; Yang, G.; Zhang, C.; Zeng, R.; Ullrich, A.; Lottspeich, F.; Chen, Z. Tyrosine phosphorylated Par3 regulates epithelial tight junction assembly promoted by EGFR signaling. EMBO J., 2006, 25, 5058-5070.
168. Neville, D. C.; Rozanas, C. R.; Price, E. M.; Gruis, D. B.; Verkman, A. S.; Townsend, R. R. Evidence for phosphorylation of serine 753 in CFTR using a novel metal-ion affinity resin and matrix-assisted laser desorption mass spectrometry. Protein Sci., 1997, 6, 2436-2445.
169. rd Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis. J. Proteome Res., 2008, 7, 1346-1351.
170. Wang, B.; Malik, R.; Nigg, E. A.; Korner, R. Evaluation of the low-specificity protease elastase for large-scale phosphoproteome analysis. Anal. Chem., 2008, 80, 9526-9533.